Thus, we provide additional clinicopathological support for the role of PPP2R2A (B55α) as a tumor suppressor in BC and present pilot evidence that the PPP2R2A-/low/Cyclin D1high phenotype may be clinically relevant in BC and should be further investigated. The gene discussed is PPP2R2A; the disease is neoplasm.